|Natural history of progression after PSA elevation following radical prostatectomy|
CR Pound, AW Partin, MA Eisenberger, DW Chan, JD Pearson, PC Walsh
Jama 281 (17), 1591-1597, 1999
|The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer|
AW Partin, J Yoo, HB Carter, JD Pearson, DW Chan, JI Epstein, PC Walsh
The Journal of urology 150 (1), 110-114, 1993
|Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease|
HB Carter, JD Pearson, EJ Metter, LJ Brant, DW Chan, R Andres, ...
Jama 267 (16), 2215-2220, 1992
|Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer|
J Li, Z Zhang, J Rosenzweig, YY Wang, DW Chan
Clinical chemistry 48 (8), 1296-1304, 2002
|Proteogenomics connects somatic mutations to signalling in breast cancer|
P Mertins, DR Mani, KV Ruggles, MA Gillette, KR Clauser, P Wang, ...
Nature 534 (7605), 55-62, 2016
|Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer|
Z Zhang, RC Bast Jr, Y Yu, J Li, LJ Sokoll, AJ Rai, JM Rosenzweig, ...
Cancer research 64 (16), 5882-5890, 2004
|Proteogenomic characterization of human colon and rectal cancer|
B Zhang, J Wang, X Wang, J Zhu, Q Liu, Z Shi, MC Chambers, ...
Nature 513 (7518), 382-387, 2014
|Immunosensors—principles and applications to clinical chemistry|
PB Luppa, LJ Sokoll, DW Chan
Clinica chimica acta 314 (1-2), 1-26, 2001
|Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 …|
GS Omenn, DJ States, M Adamski, TW Blackwell, R Menon, H Hermjakob, ...
Proteomics 5 (13), 3226-3245, 2005
|Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia|
AW Partin, HB Carter, DW Chan, JI Epstein, JE Oesterling, RC Rock, ...
The Journal of urology 143 (4), 747-752, 1990
|National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers|
CM Sturgeon, MJ Duffy, UH Stenman, H Lilja, N Brunner, DW Chan, ...
Clinical chemistry 54 (12), e11-e79, 2008
|Integrated proteogenomic characterization of human high-grade serous ovarian cancer|
H Zhang, T Liu, Z Zhang, SH Payne, B Zhang, JE McDermott, JY Zhou, ...
Cell 166 (3), 755-765, 2016
|Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy|
JE Oesterling, DW Chan, JI Epstein, AW Kimball Jr, DJ Bruzek, RC Rock, ...
The Journal of urology 139 (4), 766-772, 1988
|Standard operating procedures for serum and plasma collection: early detection research network consensus statement standard operating procedure integration working group|
MK Tuck, DW Chan, D Chia, AK Godwin, WE Grizzle, KE Krueger, W Rom, ...
Journal of proteome research 8 (1), 113-117, 2009
|HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples|
AJ Rai, CA Gelfand, BC Haywood, DJ Warunek, J Yi, MD Schuchard, ...
Proteomics 5 (13), 3262-3277, 2005
|A multicenter study of [-2] pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to …|
WJ Catalona, AW Partin, MG Sanda, JT Wei, GG Klee, CH Bangma, ...
The Journal of urology 185 (5), 1650-1655, 2011
|Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology|
C Rosty, L Christa, S Kuzdzal, WM Baldwin, ML Zahurak, F Carnot, ...
Cancer research 62 (6), 1868-1875, 2002
|Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approach|
SA Carr, SE Abbatiello, BL Ackermann, C Borchers, B Domon, ...
Molecular & Cellular Proteomics 13 (3), 907-917, 2014
|Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of …|
OJ Semmes, Z Feng, BL Adam, LL Banez, WL Bigbee, D Campos, ...
Clinical Chemistry 51 (1), 102-112, 2005
|Translation of proteomic biomarkers into FDA approved cancer diagnostics: issues and challenges|
AK Füzéry, J Levin, MM Chan, DW Chan
Clinical proteomics 10 (1), 1-14, 2013